These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20973954)

  • 1. Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.
    De Nardo CM; Lenzo JC; Pobjoy J; Hamilton JA; Cook AD
    Arthritis Res Ther; 2010; 12(5):R199. PubMed ID: 20973954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.
    Cook AD; De Nardo CM; Braine EL; Turner AL; Vlahos R; Way KJ; Beckman SK; Lenzo JC; Hamilton JA
    Arthritis Res Ther; 2010; 12(2):R37. PubMed ID: 20196869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.
    Cook AD; Braine EL; Campbell IK; Hamilton JA
    Am J Pathol; 2002 Mar; 160(3):917-26. PubMed ID: 11891190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models.
    Li J; Guo Y; Holmdahl R; Ny T
    Arthritis Rheum; 2005 Aug; 52(8):2541-8. PubMed ID: 16052596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
    van Lent PL; Grevers L; Blom AB; Sloetjes A; Mort JS; Vogl T; Nacken W; van den Berg WB; Roth J
    Ann Rheum Dis; 2008 Dec; 67(12):1750-8. PubMed ID: 18055478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-type plasminogen activator deficiency exacerbates arthritis.
    Yang YH; Carmeliet P; Hamilton JA
    J Immunol; 2001 Jul; 167(2):1047-52. PubMed ID: 11441114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
    Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
    Li J; Ny A; Leonardsson G; Nandakumar KS; Holmdahl R; Ny T
    Am J Pathol; 2005 Mar; 166(3):783-92. PubMed ID: 15743790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
    Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
    J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.
    García S; Forteza J; López-Otin C; Gómez-Reino JJ; González A; Conde C
    Arthritis Res Ther; 2010; 12(6):R224. PubMed ID: 21190566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production.
    Pinto LG; Talbot J; Peres RS; Franca RF; Ferreira SH; Ryffel B; Aves-Filho JC; Figueiredo F; Cunha TM; Cunha FQ
    Arthritis Res Ther; 2015 Sep; 17(1):235. PubMed ID: 26330334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
    Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
    Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of urokinase-type plasminogen activator in leukocyte infiltration and inflammatory responses in mice corneas treated with lipopolysaccharide.
    Sugioka K; Kodama A; Yoshida K; Okada K; Mishima H; Aomatsu K; Matsuo O; Shimomura Y
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5338-50. PubMed ID: 25061113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
    Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
    Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor type-1 deficiency attenuates murine antigen-induced arthritis.
    Van Ness K; Chobaz-Péclat V; Castellucci M; So A; Busso N
    Rheumatology (Oxford); 2002 Feb; 41(2):136-41. PubMed ID: 11886960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
    Ronday HK; Smits HH; Quax PH; van der Pluijm G; Löwik CW; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1997 Jan; 36(1):9-15. PubMed ID: 9117184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.